SEC Comment Letter 0000000000-24-000518 to BloomZ Inc. (BLMZ) (CIK 0001984014) (BLMZF)
BloomZ Inc. (BLMZ) (CIK 0001984014)
Date: Jan. 16, 2024 · CIK: 0001984014 · Accession: 0000000000-24-000518
AI Filing Summary & Sentiment
File numbers found in text: 333-275223
Show Raw Text
United States securities and exchange commission logo
January 16, 2024
Kazusa Aranami
Chief Executive Officer
BloomZ Inc.
Toyo Recording 1F, 4-5-19 Akasaka
Minato-ku, Tokyo 107-0052
Japan
Re:BloomZ Inc.
Amendment No. 1 to Registration Statement on Form F-1
Filed December 27, 2023
File No. 333-275223
Dear Kazusa Aranami:
We have reviewed your amended registration statement and have the following
comment(s).
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our November 27, 2023 letter.
Amendment No.1 to Registration Statement on Form F-1
General
1.We note your disclosure on the cover page of the selling shareholder prospectus that the
sales price of the resale shares will be fixed at the initial public offering price per public
offering ordinary share until such time as the shares are listed on Nasdaq, and thereafter
the resale shares may be sold at prevailing market prices, prices related to prevailing
market prices or at privately negotiated prices. However, we note your disclosure that it is
a condition to closing of the offering of the resale shares that the ordinary shares qualify
for listing on Nasdaq, and the disclosure under "Plan of Distribution" in the resale
prospectus that the selling shareholders will not offer for sale the resale shares covered by
the resale prospectus at the IPO price until such time as the ordinary shares are listed on
Nasdaq. Please revise to clarify whether you disclosure is intended to permit the selling
FirstName LastNameKazusa Aranami
Comapany NameBloomZ Inc.
January 16, 2024 Page 2
FirstName LastName
Kazusa Aranami
BloomZ Inc.
January 16, 2024
Page 2
shareholders to sell prior to the successful listing of your ordinary shares on Nasdaq, and,
if so, please explain how this will work given that the closing of the resale offering is
contingent upon the ordinary shares qualifying for listing on Nasdaq, and that the selling
shareholders will not offer the resale shares until the ordinary shares are listed. If selling
shareholders will only sell their shares at market prices following the pricing of the public
offering and the listing of the shares on Nasdaq, please make this clear and please include
a placeholder for the initial public offering price as well as the most recent trading price
and confirm that you will include such information in the Rule 424(b) prospectus filed in
connection with this resale offering.
2.It appears that some of the disclosure in the public offering prospectus is not applicable to
the public offering, and should instead be included only in the resale prospectus. For
example, the disclosure on the public offering prospectus cover page suggests that the
resale shares are being offered and described in the public offering prospectus, as you
include the resale shares as part of the definition of "offering" used in that prospectus. In
addition, under "About this Prospectus," you state that "[w]e, the Selling Shareholders and
the underwriters... have not authorized anyone to make representations other than those
contained in this prospectus," when the selling shareholders are not offering any shares
under that prospectus. Please advise and revise as necessary.
Please contact Tony Watson at 202-551-3318 or Rufus Decker at 202-551-3769 if you
have questions regarding comments on the financial statements and related matters. Please
contact Alyssa Wall at 202-551-8106 or Erin Jaskot at 202-551-3442 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Ying Li